Mazor Robotics Receives Three Additional Orders for the Renaissance System; Expands Presence into New US Metropolitan Markets
December 23 2015 - 4:30AM
Business Wire
- Brings Fourth Quarter System Orders to Date
to Seven -
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of
innovative guidance systems and complementary products, today
reported three additional fourth quarter 2015 orders for the
Renaissance system, including from hospitals in new US metropolitan
markets. The first system was installed in a Philadelphia
metropolitan area hospital. The second system will be installed in
a Birmingham, Alabama metropolitan area hospital. A third system
was ordered internationally from a distribution partner. These
represent orders for the fifth, sixth and seventh Renaissance
systems to date in the fourth quarter ending December 31, 2015.
“Our success in the quarter, with orders to date in a variety of
targeted US markets reflects our expanded sales footprint,
increasing effectiveness of the sales organization and process, and
the increasing awareness of the Renaissance system,” commented Ori
Hadomi, Chief Executive Officer. “With seven systems ordered to
date during the current quarter, we remain confident that our team
will sell more Renaissance systems in the second half of 2015 as
compared to the first half of the year.”
The Company will announce the total number of system orders for
the fourth quarter ending December 31, 2015 during the first week
of January 2016.
About Mazor
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing
through innovation by developing and introducing revolutionary
robotic-based technology and products aimed at redefining the gold
standard of quality care. Mazor Robotics Renaissance® Guidance
System enables surgeons to conduct spine and brain procedures in a
more accurate and secure manner. For more information, please visit
www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other securities laws. Any statements in this release about
future expectations, plans or prospects for the Company, including
without limitation, statements that the Company is confident it
will sell more Renaissance systems in the second half of 2015 as
compared to the first half of 2015, and other statements containing
the words “believes,” “anticipates,” “plans,” “expects,” “will” and
similar expressions are forward-looking statements. These
statements are only predictions based on Mazor's current
expectations and projections about future events. There are
important factors that could cause Mazor's actual results, level of
activity, performance or achievements to differ materially from the
results, level of activity, performance or achievements expressed
or implied by the forward-looking statements. Those factors
include, but are not limited to, the impact of general economic
conditions, competitive products, product demand and market
acceptance risks, reliance on key strategic alliances, fluctuations
in operating results, and other factors indicated in Mazor's
filings with the Securities and Exchange Commission (SEC) including
those discussed under the heading "Risk Factors" in Mazor’s annual
report on Form 20-F filed with the SEC on April 29, 2015 and in
subsequent filings with the SEC. For more details, refer to Mazor's
SEC filings. Mazor undertakes no obligation to update
forward-looking statements to reflect subsequent occurring events
or circumstances, or to changes in our expectations, except as may
be required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151223005070/en/
U.S. Contacts: EVC GroupInvestorsMichael Polyviou,
212-850-6020mpolyviou@evcgroup.comDoug Sherk,
415-652-9100dsherk@evcgroup.comorMediaDavid Schemelia,
646-201-5431dave@evcgroup.com
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Apr 2023 to Apr 2024